MTOR and colorectal cancer: It has been shown by Kim et al[11] that when DDR1 inhibitor DDR1-IN-1 (which is less potent than 7rh in this study) was combined with AZD8055, an mTOR inhibitor, the antiproliferative activity was substantially potentiated in colorectal cancer cells.